JAKUB TOLAR to Immunotherapy, Adoptive
This is a "connection" page, showing publications JAKUB TOLAR has written about Immunotherapy, Adoptive.
Connection Strength
0.370
-
Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in?vivo cytokine administration: implications for clinical therapy. Biol Blood Marrow Transplant. 2014 Aug; 20(8):1252-7.
Score: 0.249
-
Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T. Int J Mol Sci. 2018 Jan 24; 19(2).
Score: 0.081
-
Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice. Mol Ther. 2018 06 06; 26(6):1423-1434.
Score: 0.020
-
Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies. Mol Ther. 2008 Mar; 16(3):580-9.
Score: 0.010
-
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood. 2007 Nov 01; 110(9):3480-8.
Score: 0.010